All lobbying filings

ACADIA PHARMACEUTICALS

Lobbying for ACADIA PHARMACEUTICALS

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $590,000.00 expenses · posted Jan 19, 2026

Official filing document

Bills named in this filing 7

HR 946
ORPHAN Cures Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 1414
Cameron’s Law
HR 1262
Mikaela Naylon Give Kids a Chance Act
HR 3731
Small Biotech Innovation Act

Lobbying activity 3

Medicare/Medicaid

Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.

Taxation/Internal Revenue Code

Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).

Health Issues

Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.